Page last updated: 2024-11-06

piperonyl butoxide and Body Weight, Fetal

piperonyl butoxide has been researched along with Body Weight, Fetal in 2 studies

Research Excerpts

ExcerptRelevanceReference
" Adverse clinical observations (urogenital wetness and staining) occurred in the 1000 mg/kg/day dose group."1.72Developmental and reproduction toxicity of piperonyl butoxide part 1 developmental safety of piperonyl butoxide in the CD® (Sprague Dawley) rat. ( Hauswirth, JW; Hoberman, AM, 2022)
"Cyclophosphamide reduced fetal body weights by 30-40% without increasing resorption or death."1.35Preventive effect of piperonyl butoxide on cyclophosphamide-induced teratogenesis in rats. ( Choi, YJ; Jang, JY; Joo, SS; Kang, H; Kim, KY; Kim, S; Kim, TK; Kim, YB; Lee, SH; Oh, J; Park, D; Shin, S, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hoberman, AM1
Hauswirth, JW1
Park, D1
Kim, S1
Kang, H1
Oh, J1
Jang, JY1
Shin, S1
Kim, TK1
Choi, YJ1
Lee, SH1
Kim, KY1
Joo, SS1
Kim, YB1

Other Studies

2 other studies available for piperonyl butoxide and Body Weight, Fetal

ArticleYear
Developmental and reproduction toxicity of piperonyl butoxide part 1 developmental safety of piperonyl butoxide in the CD® (Sprague Dawley) rat.
    Reproductive toxicology (Elmsford, N.Y.), 2022, Volume: 112

    Topics: Animals; Body Weight; Female; Fetal Weight; Fetus; Piperonyl Butoxide; Pregnancy; Rats; Rats, Spragu

2022
Preventive effect of piperonyl butoxide on cyclophosphamide-induced teratogenesis in rats.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2009, Volume: 86, Issue:5

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Bone Development; Cyclophosphamide; Cyto

2009